Tuesday, October 24th
2:30 PM – 3:30 PM
Location: Grand Ballroom—Salons 1 & 2 (7th Floor)
Panelists will discuss their different approaches and strategies to mergers & acquisitions, corporate finance and advisory services.
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing round to support its European commercialization. Outcome Capital served as the exclusive strategic and financial advisor to the company. ELIOS’ implant-free, minimally invasive Excimer Laser Trabeculostomy glaucoma procedure is approved […]Read More
Outcome Capital Life Science Market Pulse July 2022 Click to view our LifeSciences Pulse NewsletterDownload